Screening strategy for non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, affecting approximately 25% of the general population worldwide, and is forecasted to increase global health burden in the 21st century. With the advancement of non-invasive tests for assessing and monitoring of stea...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , |
|---|---|
| Fformat: | Revisão |
| Iaith: | Saesneg |
| Cyhoeddwyd: |
2022
|
| Mynediad Ar-lein: | https://doi.org/10.3350/cmh.2022.0336 https://www.e-cmh.org/upload/pdf/cmh-2022-0336.pdf |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|